nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—PDHB—kidney cancer	0.0184	0.0778	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Basigin interactions—L1CAM—kidney cancer	0.0145	0.0614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC52A2—cortex of kidney—kidney cancer	0.0143	0.123	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—cardiac atrium—kidney cancer	0.0136	0.117	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—LDHB—kidney cancer	0.0112	0.0472	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHB—kidney cancer	0.0112	0.0471	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Gemcitabine—kidney cancer	0.0102	1	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—PDHB—kidney cancer	0.00996	0.042	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—nephron tubule—kidney cancer	0.00949	0.0818	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—renal system—kidney cancer	0.00904	0.078	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—kidney—kidney cancer	0.00874	0.0754	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—cortex of kidney—kidney cancer	0.00851	0.0734	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—kidney cancer	0.00845	0.0357	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—CRABP1—kidney cancer	0.00824	0.0348	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—cortex of kidney—kidney cancer	0.00812	0.07	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—gonad—kidney cancer	0.00811	0.0699	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—Basigin interactions—L1CAM—kidney cancer	0.00786	0.0332	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—gonad—kidney cancer	0.00774	0.0667	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—cardiac atrium—kidney cancer	0.00773	0.0666	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—LDHB—kidney cancer	0.00676	0.0285	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—LDHB—kidney cancer	0.00603	0.0255	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHB—kidney cancer	0.00602	0.0254	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—renal system—kidney cancer	0.00549	0.0474	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—kidney—kidney cancer	0.00531	0.0458	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—kidney cancer	0.00498	0.021	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—gonad—kidney cancer	0.00493	0.0425	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—cardiac atrium—kidney cancer	0.00492	0.0424	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—L1CAM—kidney cancer	0.00484	0.0204	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00471	0.0199	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—kidney cancer	0.00456	0.0193	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—CRABP1—kidney cancer	0.00445	0.0188	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—PDHB—kidney cancer	0.00433	0.0183	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00373	0.0157	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—LDHB—kidney cancer	0.00365	0.0154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—FH—kidney cancer	0.00328	0.0138	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—kidney cancer	0.00269	0.0114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—GRB7—kidney cancer	0.00265	0.0112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—LDHB—kidney cancer	0.00262	0.0111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—L1CAM—kidney cancer	0.00261	0.011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—PDHB—kidney cancer	0.00234	0.00986	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00214	0.00904	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00201	0.00849	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—RYR1—kidney cancer	0.00201	0.00847	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—kidney cancer	0.00193	0.00815	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—RYR1—kidney cancer	0.0019	0.008	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—FH—kidney cancer	0.00177	0.00747	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00169	0.00715	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—ANXA2—kidney cancer	0.00164	0.00693	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.0015	0.00632	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—GRB7—kidney cancer	0.00143	0.00604	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—LDHB—kidney cancer	0.00142	0.00597	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—L1CAM—kidney cancer	0.00131	0.00554	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—ATP7B—kidney cancer	0.00115	0.00486	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00113	0.00477	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00109	0.00461	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00109	0.00459	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00109	0.00459	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00109	0.00459	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—kidney cancer	0.00104	0.0044	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ANXA2—kidney cancer	0.000994	0.0042	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000914	0.00386	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000893	0.00377	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000863	0.00364	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000861	0.00363	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000861	0.00363	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000861	0.00363	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KCNMA1—kidney cancer	0.000824	0.00348	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000809	0.00342	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACY1—kidney cancer	0.000767	0.00324	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GRB7—kidney cancer	0.000719	0.00303	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—L1CAM—kidney cancer	0.000708	0.00299	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000698	0.00295	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITPR2—kidney cancer	0.000668	0.00282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PDHB—kidney cancer	0.000652	0.00275	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—KCNMA1—kidney cancer	0.000618	0.00261	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CCBL1—kidney cancer	0.000613	0.00259	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000596	0.00252	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000574	0.00242	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000555	0.00234	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.00054	0.00228	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ANXA2—kidney cancer	0.000537	0.00227	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GLIPR1—kidney cancer	0.000532	0.00224	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPAT—kidney cancer	0.000532	0.00224	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00052	0.00219	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000496	0.0021	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—FH—kidney cancer	0.000494	0.00209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—APRT—kidney cancer	0.000494	0.00209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA1—kidney cancer	0.00049	0.00207	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000482	0.00204	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000466	0.00197	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GPC3—kidney cancer	0.000465	0.00196	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000465	0.00196	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000465	0.00196	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000465	0.00196	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—ACHE—kidney cancer	0.000457	0.00193	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA2—kidney cancer	0.000456	0.00193	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000454	0.00192	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CA2—kidney cancer	0.000452	0.00191	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KCNMA1—kidney cancer	0.000445	0.00188	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALAD—kidney cancer	0.000441	0.00186	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000438	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000438	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ST3GAL2—kidney cancer	0.00043	0.00182	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALDH1A1—kidney cancer	0.00042	0.00177	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACY1—kidney cancer	0.000414	0.00175	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IGF2—kidney cancer	0.000411	0.00173	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A3—kidney cancer	0.000403	0.0017	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PGK1—kidney cancer	0.000403	0.0017	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000401	0.00169	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000401	0.00169	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000401	0.00169	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BCHE—kidney cancer	0.000398	0.00168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—LDHB—kidney cancer	0.000395	0.00167	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GRB7—kidney cancer	0.000388	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITPR2—kidney cancer	0.000361	0.00152	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000353	0.000555	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000353	0.000554	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000353	0.00149	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fatigue—Vincristine—kidney cancer	0.000352	0.000553	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PDHB—kidney cancer	0.000352	0.00149	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Erlotinib—kidney cancer	0.000352	0.000553	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Erlotinib—kidney cancer	0.000352	0.000552	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Paclitaxel—kidney cancer	0.000352	0.000552	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Gemcitabine—kidney cancer	0.000351	0.000551	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Capecitabine—kidney cancer	0.00035	0.00055	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Erlotinib—kidney cancer	0.00035	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Capecitabine—kidney cancer	0.00035	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Paclitaxel—kidney cancer	0.00035	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Vincristine—kidney cancer	0.00035	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Vincristine—kidney cancer	0.00035	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Doxorubicin—kidney cancer	0.000349	0.000549	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Gemcitabine—kidney cancer	0.000348	0.000547	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Capecitabine—kidney cancer	0.000348	0.000547	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Sunitinib—kidney cancer	0.000347	0.000544	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000346	0.00146	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Gemcitabine—kidney cancer	0.000346	0.000543	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Vinblastine—kidney cancer	0.000345	0.000542	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Gemcitabine—kidney cancer	0.000345	0.000541	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Paclitaxel—kidney cancer	0.000345	0.000541	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Everolimus—kidney cancer	0.000344	0.00054	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Sorafenib—kidney cancer	0.000344	0.00054	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Paclitaxel—kidney cancer	0.000343	0.000539	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CA9—kidney cancer	0.000343	0.00145	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Angiopathy—Capecitabine—kidney cancer	0.00034	0.000534	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Capecitabine—kidney cancer	0.000339	0.000532	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Paclitaxel—kidney cancer	0.000339	0.000532	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Paclitaxel—kidney cancer	0.000339	0.000532	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Paclitaxel—kidney cancer	0.000339	0.000532	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Capecitabine—kidney cancer	0.000338	0.000531	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Paclitaxel—kidney cancer	0.000338	0.00053	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Gemcitabine—kidney cancer	0.000337	0.000529	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Dactinomycin—kidney cancer	0.000337	0.000529	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Capecitabine—kidney cancer	0.000337	0.000528	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000336	0.000528	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000335	0.000526	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Gemcitabine—kidney cancer	0.000334	0.000525	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Vincristine—kidney cancer	0.000334	0.000525	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Sorafenib—kidney cancer	0.000332	0.000522	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Gemcitabine—kidney cancer	0.000332	0.000521	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Gemcitabine—kidney cancer	0.000332	0.000521	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Erlotinib—kidney cancer	0.000332	0.000521	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Capecitabine—kidney cancer	0.000331	0.00052	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Paclitaxel—kidney cancer	0.000331	0.00052	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CCBL1—kidney cancer	0.000331	0.0014	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Sunitinib—kidney cancer	0.000331	0.000519	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Doxorubicin—kidney cancer	0.000329	0.000516	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Capecitabine—kidney cancer	0.000329	0.000516	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Dactinomycin—kidney cancer	0.000328	0.000515	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Paclitaxel—kidney cancer	0.000327	0.000514	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Doxorubicin—kidney cancer	0.000327	0.000514	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Capecitabine—kidney cancer	0.000326	0.000513	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Doxorubicin—kidney cancer	0.000325	0.00051	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Paclitaxel—kidney cancer	0.000325	0.00051	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Vincristine—kidney cancer	0.000323	0.000507	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Paclitaxel—kidney cancer	0.000323	0.000506	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Capecitabine—kidney cancer	0.00032	0.000502	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Sunitinib—kidney cancer	0.00032	0.000502	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Gemcitabine—kidney cancer	0.00032	0.000502	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Paclitaxel—kidney cancer	0.000319	0.000502	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Sorafenib—kidney cancer	0.000319	0.000501	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Doxorubicin—kidney cancer	0.000319	0.000501	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Paclitaxel—kidney cancer	0.000318	0.0005	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Sorafenib—kidney cancer	0.000317	0.000497	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Sorafenib—kidney cancer	0.000316	0.000497	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Capecitabine—kidney cancer	0.000316	0.000496	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Paclitaxel—kidney cancer	0.000315	0.000495	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000315	0.000494	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Sorafenib—kidney cancer	0.000315	0.000494	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Capecitabine—kidney cancer	0.000314	0.000493	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Paclitaxel—kidney cancer	0.000314	0.000493	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Dactinomycin—kidney cancer	0.000313	0.000492	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Doxorubicin—kidney cancer	0.000312	0.000491	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Paclitaxel—kidney cancer	0.00031	0.000486	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000308	0.000484	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Doxorubicin—kidney cancer	0.000308	0.000484	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Capecitabine—kidney cancer	0.000308	0.000483	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Sunitinib—kidney cancer	0.000307	0.000483	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Capecitabine—kidney cancer	0.000306	0.00048	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Sunitinib—kidney cancer	0.000305	0.000478	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Sunitinib—kidney cancer	0.000304	0.000478	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Doxorubicin—kidney cancer	0.000304	0.000477	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Sunitinib—kidney cancer	0.000303	0.000475	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Doxorubicin—kidney cancer	0.000302	0.000474	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Capecitabine—kidney cancer	0.000302	0.000474	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Vincristine—kidney cancer	0.000301	0.000473	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Sorafenib—kidney cancer	0.000298	0.000468	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000296	0.000464	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000295	0.00124	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Paclitaxel—kidney cancer	0.000294	0.000461	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Capecitabine—kidney cancer	0.000293	0.000461	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Vincristine—kidney cancer	0.000293	0.000461	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Capecitabine—kidney cancer	0.000293	0.00046	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.000292	0.00123	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Paclitaxel—kidney cancer	0.000292	0.000458	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CRABP1—kidney cancer	0.000291	0.00123	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Dactinomycin—kidney cancer	0.000291	0.000457	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Paclitaxel—kidney cancer	0.000289	0.000455	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Paclitaxel—kidney cancer	0.000289	0.000453	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Capecitabine—kidney cancer	0.000289	0.000453	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Dactinomycin—kidney cancer	0.000288	0.000453	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GLIPR1—kidney cancer	0.000287	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPAT—kidney cancer	0.000287	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Sunitinib—kidney cancer	0.000287	0.000451	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Capecitabine—kidney cancer	0.000287	0.000451	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Paclitaxel—kidney cancer	0.000286	0.000449	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Paclitaxel—kidney cancer	0.000282	0.000443	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Capecitabine—kidney cancer	0.000282	0.000443	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00028	0.00044	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Paclitaxel—kidney cancer	0.00028	0.00044	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Vincristine—kidney cancer	0.00028	0.000439	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Doxorubicin—kidney cancer	0.000279	0.000438	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Gemcitabine—kidney cancer	0.000278	0.000437	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Capecitabine—kidney cancer	0.000278	0.000436	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Capecitabine—kidney cancer	0.000278	0.000436	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Capecitabine—kidney cancer	0.000278	0.000436	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Paclitaxel—kidney cancer	0.000278	0.000436	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Paclitaxel—kidney cancer	0.000278	0.000436	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Capecitabine—kidney cancer	0.000277	0.000435	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000276	0.000433	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Doxorubicin—kidney cancer	0.000275	0.000432	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Doxorubicin—kidney cancer	0.000273	0.000429	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Doxorubicin—kidney cancer	0.000272	0.000428	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Capecitabine—kidney cancer	0.000272	0.000427	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Dactinomycin—kidney cancer	0.000272	0.000427	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ITPR2—kidney cancer	0.000271	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Vincristine—kidney cancer	0.00027	0.000424	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Doxorubicin—kidney cancer	0.000269	0.000423	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Doxorubicin—kidney cancer	0.000269	0.000423	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Capecitabine—kidney cancer	0.000269	0.000422	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000268	0.00113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Paclitaxel—kidney cancer	0.000268	0.00042	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FH—kidney cancer	0.000267	0.00113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—APRT—kidney cancer	0.000267	0.00113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Capecitabine—kidney cancer	0.000266	0.000418	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000266	0.000417	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Gemcitabine—kidney cancer	0.000265	0.000417	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000265	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA1—kidney cancer	0.000265	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Capecitabine—kidney cancer	0.000265	0.000416	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—kidney cancer	0.000263	0.000412	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Capecitabine—kidney cancer	0.000262	0.000412	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—RAF1—kidney cancer	0.000262	0.00111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Capecitabine—kidney cancer	0.000261	0.00041	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Vincristine—kidney cancer	0.00026	0.000408	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Capecitabine—kidney cancer	0.000259	0.000406	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Paclitaxel—kidney cancer	0.000258	0.000405	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Vincristine—kidney cancer	0.000258	0.000405	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Capecitabine—kidney cancer	0.000258	0.000404	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Vincristine—kidney cancer	0.000258	0.000404	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—kidney cancer	0.000257	0.000403	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Paclitaxel—kidney cancer	0.000257	0.000403	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Vincristine—kidney cancer	0.000256	0.000402	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—kidney cancer	0.000254	0.000399	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Capecitabine—kidney cancer	0.000254	0.000399	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—kidney cancer	0.000253	0.000397	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPC3—kidney cancer	0.000251	0.00106	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000248	0.00105	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTT1—kidney cancer	0.000247	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACHE—kidney cancer	0.000247	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Gemcitabine—kidney cancer	0.000247	0.000387	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA2—kidney cancer	0.000246	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000245	0.00103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Gemcitabine—kidney cancer	0.000245	0.000384	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Gemcitabine—kidney cancer	0.000244	0.000384	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA2—kidney cancer	0.000244	0.00103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Gemcitabine—kidney cancer	0.000243	0.000381	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Vincristine—kidney cancer	0.000243	0.000381	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000243	0.000381	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—kidney cancer	0.000242	0.000381	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Capecitabine—kidney cancer	0.000241	0.000378	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—kidney cancer	0.000241	0.000378	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—kidney cancer	0.00024	0.000377	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Capecitabine—kidney cancer	0.000239	0.000376	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Paclitaxel—kidney cancer	0.000239	0.000376	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—kidney cancer	0.000239	0.000375	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—kidney cancer	0.000238	0.000374	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALAD—kidney cancer	0.000238	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—kidney cancer	0.000238	0.000373	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Capecitabine—kidney cancer	0.000238	0.000373	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—kidney cancer	0.000237	0.000372	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000237	0.000999	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Capecitabine—kidney cancer	0.000235	0.000368	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SCARB1—kidney cancer	0.000234	0.000987	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Paclitaxel—kidney cancer	0.000233	0.000366	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ST3GAL2—kidney cancer	0.000232	0.00098	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Capecitabine—kidney cancer	0.000232	0.000364	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS1—kidney cancer	0.000231	0.000977	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Gemcitabine—kidney cancer	0.00023	0.000362	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00023	0.000361	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Capecitabine—kidney cancer	0.00023	0.000361	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Capecitabine—kidney cancer	0.000228	0.000358	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Capecitabine—kidney cancer	0.000228	0.000358	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PSMD7—kidney cancer	0.000227	0.000958	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDH1A1—kidney cancer	0.000227	0.000958	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RAF1—kidney cancer	0.000226	0.000955	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—kidney cancer	0.000226	0.000355	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—kidney cancer	0.000225	0.000354	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—kidney cancer	0.000224	0.000352	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Paclitaxel—kidney cancer	0.000222	0.000349	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IGF2—kidney cancer	0.000222	0.000937	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000221	0.000935	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Capecitabine—kidney cancer	0.00022	0.000345	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—kidney cancer	0.000219	0.000344	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—kidney cancer	0.000218	0.000343	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000218	0.000342	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—kidney cancer	0.000218	0.000342	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A3—kidney cancer	0.000218	0.000919	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PGK1—kidney cancer	0.000218	0.000919	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—kidney cancer	0.000217	0.000341	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—BCHE—kidney cancer	0.000215	0.000908	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Paclitaxel—kidney cancer	0.000215	0.000337	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—kidney cancer	0.000214	0.000335	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LDHB—kidney cancer	0.000213	0.000901	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A5—kidney cancer	0.000213	0.000897	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—kidney cancer	0.000212	0.000333	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Capecitabine—kidney cancer	0.000212	0.000332	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000211	0.000892	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Capecitabine—kidney cancer	0.000211	0.000331	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—kidney cancer	0.00021	0.00033	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—kidney cancer	0.000207	0.000324	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Paclitaxel—kidney cancer	0.000206	0.000324	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—kidney cancer	0.000206	0.000324	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC2A1—kidney cancer	0.000205	0.000867	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Paclitaxel—kidney cancer	0.000205	0.000321	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Paclitaxel—kidney cancer	0.000205	0.000321	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—kidney cancer	0.000204	0.000321	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000204	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—kidney cancer	0.000204	0.00032	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Paclitaxel—kidney cancer	0.000203	0.000319	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—kidney cancer	0.000203	0.000858	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—kidney cancer	0.000203	0.000856	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—kidney cancer	0.000202	0.000318	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000202	0.000853	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—kidney cancer	0.000198	0.000311	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Capecitabine—kidney cancer	0.000196	0.000308	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000196	0.000826	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—kidney cancer	0.000195	0.000305	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—kidney cancer	0.000193	0.000304	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Paclitaxel—kidney cancer	0.000193	0.000303	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Capecitabine—kidney cancer	0.000191	0.0003	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—kidney cancer	0.000189	0.000297	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—kidney cancer	0.000189	0.000296	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000187	0.000789	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—kidney cancer	0.000186	0.000292	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA9—kidney cancer	0.000185	0.000781	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—kidney cancer	0.000185	0.00029	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—kidney cancer	0.000182	0.000286	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Capecitabine—kidney cancer	0.000182	0.000286	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—kidney cancer	0.000182	0.000285	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—kidney cancer	0.000179	0.000281	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—kidney cancer	0.000179	0.000281	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—kidney cancer	0.000179	0.000281	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—kidney cancer	0.000179	0.00028	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000178	0.000279	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Capecitabine—kidney cancer	0.000176	0.000277	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—kidney cancer	0.000175	0.000275	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—kidney cancer	0.000173	0.000272	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—kidney cancer	0.000172	0.000727	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—kidney cancer	0.000172	0.00027	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTP1—kidney cancer	0.000171	0.000723	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—kidney cancer	0.000171	0.000268	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—RAF1—kidney cancer	0.00017	0.000716	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Capecitabine—kidney cancer	0.000169	0.000266	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—kidney cancer	0.000169	0.000265	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—kidney cancer	0.000168	0.000264	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Capecitabine—kidney cancer	0.000168	0.000264	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Capecitabine—kidney cancer	0.000168	0.000264	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Capecitabine—kidney cancer	0.000167	0.000262	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—kidney cancer	0.000167	0.000262	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—kidney cancer	0.000166	0.000261	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—kidney cancer	0.000164	0.000257	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK3—kidney cancer	0.000163	0.000688	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCB1—kidney cancer	0.000162	0.000684	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000161	0.000681	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Capecitabine—kidney cancer	0.000158	0.000249	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CRABP1—kidney cancer	0.000157	0.000664	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTM1—kidney cancer	0.000157	0.000664	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000156	0.000246	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—kidney cancer	0.000155	0.000244	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK1—kidney cancer	0.000155	0.000655	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—kidney cancer	0.000154	0.000242	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—kidney cancer	0.000153	0.00024	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—kidney cancer	0.000153	0.00024	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000152	0.000641	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—kidney cancer	0.000151	0.000237	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—kidney cancer	0.000149	0.000234	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1A1—kidney cancer	0.000149	0.00063	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000148	0.000233	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—kidney cancer	0.000148	0.000233	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—kidney cancer	0.000147	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—kidney cancer	0.000147	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—kidney cancer	0.000147	0.000618	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ITPR2—kidney cancer	0.000146	0.000617	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—kidney cancer	0.000142	0.000222	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00014	0.000221	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—kidney cancer	0.000136	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—kidney cancer	0.000136	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—kidney cancer	0.000135	0.000568	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACHE—kidney cancer	0.000133	0.000563	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTT1—kidney cancer	0.000133	0.000563	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—kidney cancer	0.00013	0.00055	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—kidney cancer	0.000127	0.000199	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SCARB1—kidney cancer	0.000126	0.000533	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS1—kidney cancer	0.000125	0.000528	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—kidney cancer	0.000123	0.000193	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSMD7—kidney cancer	0.000123	0.000517	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAF1—kidney cancer	0.000122	0.000516	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—kidney cancer	0.000118	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MAPK1—kidney cancer	0.000116	0.000491	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—BCHE—kidney cancer	0.000116	0.000491	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A5—kidney cancer	0.000115	0.000485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—kidney cancer	0.000114	0.000178	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—POMC—kidney cancer	0.000111	0.000469	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC2A1—kidney cancer	0.000111	0.000468	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—kidney cancer	0.00011	0.000462	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—kidney cancer	0.000109	0.000171	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—kidney cancer	0.000108	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—kidney cancer	0.000108	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—kidney cancer	0.000108	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000106	0.000446	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—kidney cancer	0.000102	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—kidney cancer	9.31e-05	0.000393	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTP1—kidney cancer	9.25e-05	0.00039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	9.12e-05	0.000385	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—kidney cancer	8.87e-05	0.000374	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK3—kidney cancer	8.8e-05	0.000372	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCB1—kidney cancer	8.75e-05	0.000369	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM1—kidney cancer	8.5e-05	0.000359	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK1—kidney cancer	8.38e-05	0.000354	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1A1—kidney cancer	8.05e-05	0.00034	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—kidney cancer	7.91e-05	0.000334	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—kidney cancer	7.74e-05	0.000327	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—kidney cancer	7.27e-05	0.000307	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—kidney cancer	7.03e-05	0.000297	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—POMC—kidney cancer	6.01e-05	0.000254	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—kidney cancer	5.46e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—kidney cancer	4.79e-05	0.000202	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—kidney cancer	4.18e-05	0.000176	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—kidney cancer	2.95e-05	0.000124	CbGpPWpGaD
